Health Decisions, A Division of Premier Research, is a full-service CRO specializing in clinical studies of therapeutics for women’s health indications and studies of diagnostics for all therapeutic areas. Health Decisions has conducted more than 300 trials since its inception, including 140 trials in women-only indications. Our expertise enables us to address the challenges of developing women’s health products in areas including gynecology, contraception, sexual health, infertility, obstetrics, menopause and osteoporosis as well as other indications that affect women disproportionately such as autoimmune disorders. Health Decisions is headquartered in Durham, NC.